Neurologisches Institut Konolfingen

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Parkinson disease2 trials

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• InnoMedica Schweiz AG2 trials

Running trials

• Not yet recruiting

  Estimates of the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease

  NCT06431971· Phase 2· InnoMedica Schweiz AG· Source

  Contact: Michael Schüpbach, Dr. med.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease1 recruiting

Closed trials

• Terminated

  Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients

  NCT04976127· Phase 1· InnoMedica Schweiz AG· Source